Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm

This publication has 90 references indexed in Scilit:

• Transition of a microRNA from Repressing to Activating Translation Depending on the Extent of Base Pairing with the Target
  PLOS ONE, 2013
• 95. Antisense directed against the amyloid precursor protein reduces cytokine expression in the brain and improves learning and memory in the Tg2576 mouse model of Alzheimer’s disease
  Brain, Behavior, and Immunity, 2012
• miR‐206 regulates brain‐derived neurotrophic factor in Alzheimer disease model
  Annals of Neurology, 2012
• Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency
  Cell Stem Cell, 2011
• MicroRNA-101 downregulates Alzheimer’s amyloid-β precursor protein levels in human cell cultures and is differentially expressed
  Biochemical and Biophysical Research Communications, 2011
• New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites
  Genome Research, 2009
• Most mammalian mRNAs are conserved targets of microRNAs
  Genome Research, 2008
• MicroRNA-10a Binds the 5′UTR of Ribosomal Protein mRNAs and Enhances Their Translation
  Molecular Cell, 2008
• Antisense inhibition at the β-secretase-site of β-amyloid precursor protein reduces cerebral amyloid and acetyl cholinesterase activity in Tg2576
  Neuroscience, 2007
• Antisense oligonucleotide therapy for neurodegenerative disease
  Journal of Clinical Investigation, 2006